Sense Biodetection: Timothy Still
Sense Biodetection has appointed Timothy Still as president and CEO. He also will serve on the company's board. Harry Lamble, the former CEO and cofounder of Sense will remain with the firm as chief business development officer. Still has more than 30 years of experience in the medical devices and diagnostics industries, including as chairman and CEO of consulting firm TStill Enterprises, according to LinkedIn. He has also been a non-executive board member of MDxHealth. Boston-based Sense develops instrument-free, rapid molecular tests. Its Veros platform delivers PCR-quality lab results within minutes without an instrument, according to the company.